ClinicalTrials.gov
public full text
Public Domain
Epidiolex and Drug Resistant Epilepsy in Children
This open-label, multi-center study is open to patients 1 to 18 years of age at time of enrollment with medication resistant epilepsy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Cannabidiol for Drug-Resistant Epilepsies#915304
- the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections.#1009005
- Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures#894066
- Treatment of Drug Resistant Epilepsy#892209
- Comparison of Two Dosage Adjustment Strategies of Vancomycin in Children#181793
Record · ID 1095699
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive